EUVIMEDEUVIMED entdecken
Übersichtsarbeit

NUT carcinoma and thoracic SMARCA4 ‐deficient undifferentiated tumour: facts and controversies

Akihiko Yoshida iD

Histopathology · 2024-01 · 84 (1) · 86-101

DOI: 10.1111/his.15063 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Histopathology, online erschienen am 24.10.2023. Verfasst von Akihiko Yoshida. Beteiligte Einrichtung: Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Carcinoma, Thoracic Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 110 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NUT carcinoma and thoracic SMARCA4‐deficient undifferentiated tumour are unique entities in the 5th edition of the World Health Organisation (WHO) Classification of Thoracic Tumours , whose definitions include molecular genetic abnormalities. These aggressive tumours require rapid work‐ups on biopsies, but a broad list of differential diagnoses poses challenges for practising pathologists. This review provides an update on their key clinicopathological and molecular characteristics, as well as controversies regarding tumour classification and diagnostic strategy. Phenotypical assessment plays a substantial role in diagnosis because recurrent and predictable clinicopathological findings exist, including robust immunohistochemical phenotypes. Accurate diagnosis is crucial for appropriate management and a clearer understanding of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinomaThoracic NeoplasmsHumansTranscription FactorsNuclear ProteinsDNA HelicasesBiomarkers, Tumor

Stichwörter der Autor:innen

NUTSMARCA4carcinomarhabdoid

Substanzen

Transcription FactorsNuclear ProteinsDNA HelicasesBiomarkers, TumorSMARCA4 protein, human

Autor:innen und Institutionen

  • Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Rare Cancer Center, National Cancer Center, Tokyo, Japan.

ORCID-Profile: Akihiko Yoshida

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yoshida, A. (2024). NUT carcinoma and thoracic SMARCA4 ‐deficient undifferentiated tumour: facts and controversies. Histopathology, 84(1), 86-101. https://doi.org/10.1111/his.15063

Vancouver

Yoshida A. NUT carcinoma and thoracic SMARCA4 ‐deficient undifferentiated tumour: facts and controversies. Histopathology. 2024;84(1):86-101. doi:10.1111/his.15063

BibTeX
@article{Yoshida2024,
  author = {Yoshida, Akihiko},
  title = {NUT carcinoma and thoracic SMARCA4 ‐deficient undifferentiated tumour: facts and controversies},
  journal = {Histopathology},
  year = {2024},
  volume = {84},
  number = {1},
  pages = {86--101},
  doi = {10.1111/his.15063}
}
Kostenlos starten →